President Trump steps in to aid ‘Dilbert’ creator Scott Adams in his battle against cancer, highlighting a significant intervention in healthcare access.
Story Highlights
- Trump pledges support for Scott Adams’ cancer treatment.
- Kaiser Permanente criticized for delays in treatment scheduling.
- Adams appeals directly to Trump via social media for intervention.
- Pluvicto drug reduces cancer progression risk by 28%.
Trump’s Commitment to Scott Adams
On November 2, 2025, President Donald Trump announced his intention to assist Scott Adams, the creator of the “Dilbert” comic strip, in obtaining treatment for his metastatic prostate cancer.
Adams reached out to Trump on social media, expressing frustration over delays with his healthcare provider, Kaiser Permanente, in scheduling treatment with the drug Pluvicto. Trump responded promptly, indicating his willingness to help.
Trump responds to ‘Dilbert’ creator Scott Adams’ plea for help to obtain cancer treatment: ‘On it’ https://t.co/SiLDjei42J pic.twitter.com/dqGgXTW4ok
— New York Post (@nypost) November 3, 2025
Kaiser Permanente’s Response
While Adams accused Kaiser Permanente of failing to schedule his treatment, the healthcare provider stated that Adams’ oncology team is actively working on the next steps in his cancer care. Kaiser emphasized its experience with Pluvicto, having treated over 150 patients in Northern California since the drug’s approval.
The response from Kaiser highlights a broader issue of healthcare system delays, especially for those with severe conditions requiring timely intervention. Adams’ high-profile case sheds light on these systemic challenges and the need for more efficient processes.
Impact of Pluvicto and Broader Implications
Pluvicto, a drug developed by Swiss company Novartis, has been shown to reduce the risk of cancer progression or death by 28% in prostate cancer patients. This innovative treatment combines radioactive particles with molecules targeting tumors, offering new hope for patients like Adams.
Adams’ situation underscores the importance of timely access to cutting-edge medical treatments. It also highlights the role influential figures, like President Trump, can play in advocating for individual healthcare needs.
The intervention has sparked discussions on patient rights and the responsibilities of healthcare providers to ensure timely and effective treatment.
